IP Verse

Teva Uk patent opposition analysis

Get complete Patent Opposition Report for Teva Uk

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Teva Uk

Explore patent oppositions filed by Teva Uk against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3335707Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025
EP3650019Fluticasone Furoate In The Treatment Of CopdGLAXOSMITHKLINEJun 6, 2024
EP3860590Methods For The Treatment Of SclerodermaARENA PHARMACEUTICALSFeb 29, 2024
EP3461474Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The SameGLAXOSMITHKLINEJul 13, 2021
EP2228064Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTISSep 8, 2020
EP3148521Fluticasone Furoate In The Treatment Of CopdGLAXOSMITHKLINESep 8, 2020
EP3034073Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of AsthmaCHIESI FARMACEUTICIMar 4, 2020
EP2400950Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUPFeb 21, 2020
EP2611422Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The SameGLAXOSMITHKLINEJun 14, 2019
EP3019153Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By InhalationCHIESI FARMACEUTICIJun 5, 2019

Top competitors of Teva Uk